Consumer Confidential: Drugmakers Preying on the Sick
Congress tried to show it feels America’s pain over high prescription-drug costs by calling Martin Shkreli to account. Shkreli is the former head of Turing Pharmaceuticals, currently out on $5 million bail after being charged with securities fraud and conspiracy. He became the face of Big Pharma greed after jacking up the price of a one-of-a-kind infection medication by 5,000 percent. Shkreli clammed up by citing his Fifth Amendment...
What Unites Congress? Scorn For Shkreli
Washington — A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill last week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed. But the gridlocked state of Congress virtually assures federal efforts to lower drug prices will remain in limbo for years. And even then, experts warn that the options available to Congress would not stop...
Uproar Puts Drug Pricing in Spotlight
Martin Shkreli is health care’s Gordon Gekko, its wolf of Wall Street, the symbol of all that makes people uneasy about an industry that seeks to make money by selling treatments while vowing to care only about the well-being of vulnerable patients. For days, a seething social media mob backed by an opportunistic politician or two has hammered the swaggering, 32-year-old “pharma bro” who jacked up the price of an obscure but critical...
